Medline Inc. (MDLN) shares fall after FDA warning letter
Medline shares fell about 12.8% to $36.67 on August 5, 2026, after the FDA published a warning letter detailing "significant violations of Current Good Manufacturing Practice regulations for finished pharmaceuticals." The company also reported earnings loss due to remediation efforts.